11:30 a.m.: The Sensex turned choppy in the early noon
deals after the Parliament's session began. The Sensex was down 20
points at 28,400 and the Nifty was jumped 3 points to 8,607.
11:26 a.m.: The overall breadth was neutral as 1,121 stocks were advancing while 1,173 were declining.
11:14 a.m.: Hindustan Uniliver fell 2.2 per cent to Rs 892 ahead of its first quarter earnings. The BSE FMCG index was down 1.1 per cent.
11:04 a.m.: The BSE mid-cap index was trading falt, up 0.03 per cent; Unitech, CONCOR, Glenmark, Oberoi Realty, J P Power Ventures and Neyveli Lignite were among the top losers, down 1-6 per cent each.
10:55 a.m.: Vishal Sikka, CEO on Infosys says we are very confident about our organic capability, which we will complement with acquisitions.
10:40 a.m.: The Sensex and Nifty were trading on a flat note with positive bias. The Sensex was up 54 points and the Nifty advanced 21 points.
Infosys was the top gainer on the Nifty but the gains on the benchmark were capped as Sun Pharma was facing the heat of selling pressure.
Meanwhile, the monsoon session of Parliament will start from 11:00 a.m. fate of key legislations such as land bill, implementation of goods and services tax and the real estate bill will be decided in this session of Parliament.
10:15 a.m.: Bharti Airtel shares surge 4.3 per cent to hit intraday high of Rs 448 after telecom company Orange said that it is planning to buy four African subsidiaries of Bharti Airtel.
10:10 a.m.: Sanjeev Hota, IT analysts at Sharekhan, says Infosys' Q1 numbers are better than estimates on all fronts, but the key thing to watch out is whether they are able to maintain the growth rate.
"We need to see how fast Infosys is catching up with the industry growth rate," he added. Sharekhan has a target price of Rs 1,150 on Infosys, which they are likely to revise post management commentary on Q1 performance.
10:05 a.m.: Infosys on Tuesday beat June quarter sales and profit estimates, leading to a 15 per cent bump-up in its shares. India's second biggest outsourcer reported 4.4 per cent rise in constant currency revenue growth, beating estimates of 2.5-3 per cent growth.
9:55 a.m.: The Sensex jumped nearly 100 points to hit intraday high of 28,518 and the Nifty was up 24 points at 8,627. The upmpove in the markets was led by Infosys.
9:50 a.m.: Shares of Sun Pharmaceutical Industries slumped as much as 16 per cent to Rs 799 on Tuesday after India's largest drugmaker issued an earnings warning. Sun Pharma said its revenue in fiscal 2016 would be flat at best as it struggles to fix manufacturing problems at Ranbaxy Laboratories, which it bought last year.
9:47 a.m.: Gaurang Shah of Geojit BNP Paribas said Infosys has posted stellar numbers, which should lift market sentiments.
9:45 a.m.: Dhananjay Sinha of Emkay Global told NDTV that Infosys has put up its best show in six quarters.
9:40 a.m.: The broader markets were trading in-line with the benchmark indices. The BSE mid-cap index was down 0.05 per cent and the small-cap index was up 0.14 per cent.
9:35 a.m.: On the sectoral front, selling pressure was visible in pharma, realty, oil & gas and banking stocks. On the other hand, IT, consumer durables and metal stocks were witnessing some buying interest.
From the Nifty-50 basket of stocks, 30 stocks were declining while 20 were advancing.
Sun Pharma, UltraTech Cement, Tata Power, Lupin, Grasim Industries, Asian Paints, ONGC and GAIL India were also among the laggards.
While, Infosys, Bharti Airtel, HCL Technologies, Zee Entertainment, Wipro and Coal India were among the gainers.
9:20 a.m.: The Sensex and Nifty edged lower in the opening deals as Sun Pharma was witnessing heavy selling pressure. The shares of Sun Pharma fell 14 per cent to Rs 813.
9:17 a.m.: Sensex jumped 79 points to 28,499 and the Nifty touched high of 8,630.Infosys shares surged 9 per cent on better than expected Q1 results while the gains were capped on the benchmark indices as Sun Pharma shares plunged over 10 per cent after the company gave a profit warning.
9:08 a.m.: Infosys first quarter numbers beat estimates. Consolidated revenue came in at Rs 14,354 crore versus estimate of Rs 14,066 crore and net profit came in at Rs 3,030 crore compared to estimate of Rs 3,019 crore.
9:05 a.m.: Markets will react more to the Parliament session and less to Infosys earnings, says Gaurang Shah of Geojit BNP Paribas. He continues to be cautious about markets in the short to medium term, and bullish from a long-term perspective.
9:03 a.m.: Sun Pharma shares crash 10 per cent to Rs 852 after the company gave profit warning post the markets hours yesterday.
9:00 a.m.: Rupee opens lower at 63.70/dollar against Monday's close of 63.66.
8:50 a.m.: Foreign institutional investors (FIIs) purchased shares worth Rs 714 crore while domestic institutional investors sold shares worth Rs 848 crore.
8:40 a.m.: Below are the stocks which will be in focus today:
Sun Pharmaceuticals Industries: Sun Pharma is likely face pressure in trades today after the company gave a profit warning post the market hours yesterday. Sun Pharma said on Monday that its revenue in fiscal year 2016 would be flat at best as it struggles to fix manufacturing problems at Ranbaxy Laboratories, which it bought last year.
The company might also decide to shed some low-margin businesses that it believes don't hold long-term value, it said.
Bharti Airtel: Bharti Airtel will be in focus today as reports suggest that Bharti is in talks with Orange to sell some businesses in Africa.
8:35 a.m.: The SGX Nifty was trading absolutely flat ahead of Infosys earnings. SGX Nifty was up 5 points at 8,630.
8:20 a.m.:
HDFC Bank: India' second largest private sector lender, HDFC Bank will declare its first quarter numbers today. Analysts expect the bank to post net profit of Rs 2,733 crore compared to Rs 2,233 crore in the same quarter last year. The gross non-performing assets are expected to remain unchanged at 0.9 per cent.
Hindustan Uniliver: Hindustan Uniliver's net profit is expected to come in at Rs 1,114 crore compared to Rs 1,056 crore (YOY) on sales of Rs 8,317 crore.
11:26 a.m.: The overall breadth was neutral as 1,121 stocks were advancing while 1,173 were declining.
11:14 a.m.: Hindustan Uniliver fell 2.2 per cent to Rs 892 ahead of its first quarter earnings. The BSE FMCG index was down 1.1 per cent.
11:04 a.m.: The BSE mid-cap index was trading falt, up 0.03 per cent; Unitech, CONCOR, Glenmark, Oberoi Realty, J P Power Ventures and Neyveli Lignite were among the top losers, down 1-6 per cent each.
10:55 a.m.: Vishal Sikka, CEO on Infosys says we are very confident about our organic capability, which we will complement with acquisitions.
10:40 a.m.: The Sensex and Nifty were trading on a flat note with positive bias. The Sensex was up 54 points and the Nifty advanced 21 points.
Infosys was the top gainer on the Nifty but the gains on the benchmark were capped as Sun Pharma was facing the heat of selling pressure.
Meanwhile, the monsoon session of Parliament will start from 11:00 a.m. fate of key legislations such as land bill, implementation of goods and services tax and the real estate bill will be decided in this session of Parliament.
10:15 a.m.: Bharti Airtel shares surge 4.3 per cent to hit intraday high of Rs 448 after telecom company Orange said that it is planning to buy four African subsidiaries of Bharti Airtel.
10:10 a.m.: Sanjeev Hota, IT analysts at Sharekhan, says Infosys' Q1 numbers are better than estimates on all fronts, but the key thing to watch out is whether they are able to maintain the growth rate.
"We need to see how fast Infosys is catching up with the industry growth rate," he added. Sharekhan has a target price of Rs 1,150 on Infosys, which they are likely to revise post management commentary on Q1 performance.
10:05 a.m.: Infosys on Tuesday beat June quarter sales and profit estimates, leading to a 15 per cent bump-up in its shares. India's second biggest outsourcer reported 4.4 per cent rise in constant currency revenue growth, beating estimates of 2.5-3 per cent growth.
9:55 a.m.: The Sensex jumped nearly 100 points to hit intraday high of 28,518 and the Nifty was up 24 points at 8,627. The upmpove in the markets was led by Infosys.
9:50 a.m.: Shares of Sun Pharmaceutical Industries slumped as much as 16 per cent to Rs 799 on Tuesday after India's largest drugmaker issued an earnings warning. Sun Pharma said its revenue in fiscal 2016 would be flat at best as it struggles to fix manufacturing problems at Ranbaxy Laboratories, which it bought last year.
9:47 a.m.: Gaurang Shah of Geojit BNP Paribas said Infosys has posted stellar numbers, which should lift market sentiments.
9:45 a.m.: Dhananjay Sinha of Emkay Global told NDTV that Infosys has put up its best show in six quarters.
9:40 a.m.: The broader markets were trading in-line with the benchmark indices. The BSE mid-cap index was down 0.05 per cent and the small-cap index was up 0.14 per cent.
9:35 a.m.: On the sectoral front, selling pressure was visible in pharma, realty, oil & gas and banking stocks. On the other hand, IT, consumer durables and metal stocks were witnessing some buying interest.
From the Nifty-50 basket of stocks, 30 stocks were declining while 20 were advancing.
Sun Pharma, UltraTech Cement, Tata Power, Lupin, Grasim Industries, Asian Paints, ONGC and GAIL India were also among the laggards.
While, Infosys, Bharti Airtel, HCL Technologies, Zee Entertainment, Wipro and Coal India were among the gainers.
9:20 a.m.: The Sensex and Nifty edged lower in the opening deals as Sun Pharma was witnessing heavy selling pressure. The shares of Sun Pharma fell 14 per cent to Rs 813.
9:17 a.m.: Sensex jumped 79 points to 28,499 and the Nifty touched high of 8,630.Infosys shares surged 9 per cent on better than expected Q1 results while the gains were capped on the benchmark indices as Sun Pharma shares plunged over 10 per cent after the company gave a profit warning.
9:08 a.m.: Infosys first quarter numbers beat estimates. Consolidated revenue came in at Rs 14,354 crore versus estimate of Rs 14,066 crore and net profit came in at Rs 3,030 crore compared to estimate of Rs 3,019 crore.
9:05 a.m.: Markets will react more to the Parliament session and less to Infosys earnings, says Gaurang Shah of Geojit BNP Paribas. He continues to be cautious about markets in the short to medium term, and bullish from a long-term perspective.
9:03 a.m.: Sun Pharma shares crash 10 per cent to Rs 852 after the company gave profit warning post the markets hours yesterday.
9:00 a.m.: Rupee opens lower at 63.70/dollar against Monday's close of 63.66.
8:50 a.m.: Foreign institutional investors (FIIs) purchased shares worth Rs 714 crore while domestic institutional investors sold shares worth Rs 848 crore.
8:40 a.m.: Below are the stocks which will be in focus today:
Sun Pharmaceuticals Industries: Sun Pharma is likely face pressure in trades today after the company gave a profit warning post the market hours yesterday. Sun Pharma said on Monday that its revenue in fiscal year 2016 would be flat at best as it struggles to fix manufacturing problems at Ranbaxy Laboratories, which it bought last year.
The company might also decide to shed some low-margin businesses that it believes don't hold long-term value, it said.
Bharti Airtel: Bharti Airtel will be in focus today as reports suggest that Bharti is in talks with Orange to sell some businesses in Africa.
8:35 a.m.: The SGX Nifty was trading absolutely flat ahead of Infosys earnings. SGX Nifty was up 5 points at 8,630.
8:20 a.m.:
HDFC Bank: India' second largest private sector lender, HDFC Bank will declare its first quarter numbers today. Analysts expect the bank to post net profit of Rs 2,733 crore compared to Rs 2,233 crore in the same quarter last year. The gross non-performing assets are expected to remain unchanged at 0.9 per cent.
Hindustan Uniliver: Hindustan Uniliver's net profit is expected to come in at Rs 1,114 crore compared to Rs 1,056 crore (YOY) on sales of Rs 8,317 crore.
No comments:
Post a Comment